Recursion Pharmaceuticals, Inc. RXRX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s accumulated depreciation?
- Recursion Pharmaceuticals, Inc. (RXRX) reported accumulated depreciation of $87.63M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s accumulated depreciation changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s accumulated depreciation increased by 127.2% year-over-year, from $38.57M to $87.63M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s accumulated depreciation?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s accumulated depreciation has grown at a 50.0% compound annual growth rate (CAGR), from $9.96M to $75.78M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.